Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity

Cancer Cell

Volumn 6, Issue 6, 2004, Pages 611-623

  O'Shea, Clodagh C ^a   Johnson, Leisa ^b   Bagus, Bridget ^a   Choi, Serah ^a   Nicholas, Cory ^a   Shen, Annie ^b   Boyle, Larry ^b   Pandey, Kusum ^b   Soria, Conrado ^a   Kunich, John ^b   Shen, Yuqiao ^b   Habets, Gaston ^b   Ginzinger, Dave ^a   McCormick, Frank ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ONYX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ONYX 015; PROTEIN P53; VIRUS RNA;

APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL DIVISION; CONTROLLED STUDY; GENE ACTIVATION; GENE INACTIVATION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; VIRUS REPLICATION;

ADENOVIRIDAE;

EID: 19944363519     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.11.012     Document Type: Article

References (66)

1. Arai Y., Hosoda F., Kobayashi H., Arai K., Hayashi Y., Kamada N., Kaneko Y., Ohki M. The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10. Blood. 89:1997;3936-3944
2. Attardi L.D., Reczek E.E., Cosmas C., Demicco E.G., McCurrach M.E., Lowe S.W., Jacks T. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev. 14:2000;704-718
3. Babiss L.E., Ginsberg H.S., Darnell J.E. Jr. Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport. Mol. Cell. Biol. 5:1985;2552-2558
4. Barker D.D., Berk A.J. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology. 156:1987;107-121
5. Bartel F., Taubert H., Harris L.C. Alternative and aberrant splicing of MDM2 mRNA in human cancer. Cancer Cell. 2:2002;9-15
6. Bischoff J.R., Kirn D.H., Williams A., Heise C., Horn S., Muna M., Ng L., Nye J.A., Sampson-Johannes A., Fattaey A., McCormick F. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science. 274:1996;373-376
7. Boer J., Bonten-Surtel J., Grosveld G. Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis. Mol. Cell. Biol. 18:1998;1236-1247
8. Cepko C.L., Sharp P.A. Assembly of adenovirus major capsid protein is mediated by a nonvirion protein. Cell. 31:1982;407-415
9. Chao C., Saito S., Kang J., Anderson C.W., Appella E., Xu Y. p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J. 19:2000;4967-4975
10. Chiou S.K., White E. p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis. J. Virol. 71:1997;3515-3525
11. Chipuk J.E., Kuwana T., Bouchier-Hayes L., Droin N.M., Newmeyer D.D., Schuler M., Green D.R. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 303:2004;1010-1014
12. Cuesta R., Xi Q., Schneider R.J. Adenovirus-specific translation by displacement of kinase Mnk1 from cap- initiation complex eIF4F. EMBO J. 19:2000;3465-3474
13. Cutt J.R., Shenk T., Hearing P. Analysis of adenovirus early region 4-encoded polypeptides synthesized in productively infected cells. J. Virol. 61:1987;543-552
14. Debbas M., White E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:1993;546-554
15. Dobner T., Horikoshi N., Rubenwolf S., Shenk T. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science. 272:1996;1470-1473
16. Espinosa J.M., Emerson B.M. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell. 8:2001;57-69
17. Farley D.C., Brown J.L., Leppard K.N. Activation of the early-late switch in adenovirus type 5 major late transcription unit expression by L4 gene products. J. Virol. 78:2004;1782-1791
18. Ginzinger D.G. Gene quantification using real-time quantitative PCR. An emerging technology hits the mainstream Exp. Hematol. 30:2002;503-512
19. Gonzalez R.A., Flint S.J. Effects of mutations in the adenoviral E1B 55-kilodalton protein coding sequence on viral late mRNA metabolism. J. Virol. 76:2002;4507-4519
20. Goodrum F.D., Ornelles D.A. p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection. J. Virol. 72:1998;9479-9490
21. Goodrum F.D., Ornelles D.A. Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenovirus replication. J. Virol. 73:1999;7474-7488
22. Goodrum F.D., Shenk T., Ornelles D.A. Adenovirus early region 4 34-kilodalton protein directs the nuclear localization of the early region 1B 55-kilodalton protein in primate cells. J. Virol. 70:1996;6323-6335
23. Halbert D.N., Cutt J.R., Shenk T. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J. Virol. 56:1985;250-257
24. Hall A.R., Dix B.R., O'Carroll S.J., Braithwaite A.W. p53-dependent cell death/apoptosis is required for a productive adenovirus infection. Nat. Med. 4:1998;1068-1072
25. Hann B., Balmain A. Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants. J. Virol. 77:2003;11588-11595
26. Harada J.N., Berk A.J. p53-independent and -dependent requirements for E1B-55K in adenovirus type 5 replication. J. Virol. 73:1999;5333-5344
27. Harada J.N., Shevchenko A., Pallas D.C., Berk A.J. Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J. Virol. 76:2002;9194-9206
28. Hayes B.W., Telling G.C., Myat M.M., Williams J.F., Flint S.J. The adenovirus L4 100-kilodalton protein is necessary for efficient translation of viral late mRNA species. J. Virol. 64:1990;2732-2742
29. Huang W., Flint S.J. The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export. J. Virol. 72:1998;225-235
30. Huang J.T., Schneider R.J. Adenovirus inhibition of cellular protein synthesis involves inactivation of cap-binding protein. Cell. 65:1991;271-280
31. Jimenez G.S., Nister M., Stommel J.M., Beeche M., Barcarse E.A., Zhang X.Q., O'Gorman S., Wahl G.M. A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat. Genet. 26:2000;37-43
32. Johnson L., Shen A., Boyle L., Kunich J., Pandey K., Lemmon M., Hermiston T., Giedlin M., McCormick F., Fattaey A. Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents. Cancer Cell. 1:2002;325-337
33. Khuri F.R., Nemunaitis J., Ganly I., Arseneau J., Tannock I.F., Romel L., Gore M., Ironside J., MacDougall R.H., Heise C., et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat. Med. 6:2000;879-885
34. Kirn D. Oncolytic virotherapy for cancer with the adenovirus dl1520 (ONYX-015). Results of phase I and II trials Expert Opin. Biol. Ther. 1:2001;525-538
35. Kratzer F., Rosorius O., Heger P., Hirschmann N., Dobner T., Hauber J., Stauber R.H. The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2. Oncogene. 19:2000;850-857
36. Lane D.P., Crawford L.V. T antigen is bound to a host protein in SV40-transformed cells. Nature. 278:1979;261-263
37. Leppard K.N., Shenk T. The adenovirus E1B 55 kd protein influences mRNA transport via an intranuclear effect on RNA metabolism. EMBO J. 8:1989;2329-2336
38. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331
39. Linzer D.I., Levine A.J. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell. 17:1979;43-52
40. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:2001;402-408
41. Lowe S.W., Ruley H.E. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7:1993;535-545
42. McCormick F. Cancer-specific viruses and the development of ONYX-015. Cancer Biol. Ther. 2:2003;S157-S160
43. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell. 11:2003;577-590
44. Morin N., Boulanger P. Hexon trimerization occurring in an assembly-defective, 100K temperature-sensitive mutant of adenovirus 2. Virology. 152:1986;11-31
45. Nakamura T., Largaespada D.A., Lee M.P., Johnson L.A., Ohyashiki K., Toyama K., Chen S.J., Willman C.L., Chen I.M., Feinberg A.P., et al. Feb). Fusion of the nucleoporin gene NUP. 98(to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat. Genet. 12):1996;154-158
46. Nemunaitis J., Ganly I., Khuri F., Arseneau J., Kuhn J., McCarty T., Landers S., Maples P., Romel L., Randlev B., et al. Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer. A phase II trial Cancer Res. 60:2000;6359-6366
47. Oren M. Decision making by p53. Life, death and cancer Cell Death Differ. 10:2003;431-442
48. Orlando J.S., Ornelles D.A. E4orf6 variants with separate abilities to augment adenovirus replication and direct nuclear localization of the E1B 55-kilodalton protein. J. Virol. 76:2002;1475-1487
49. Pilder S., Moore M., Logan J., Shenk T. The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol. Cell. Biol. 6:1986;470-476
50. Querido E., Marcellus R.C., Lai A., Charbonneau R., Teodoro J.G., Ketner G., Branton P.E. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J. Virol. 71:1997;3788-3798
51. Querido E., Blanchette P., Yan Q., Kamura T., Morrison M., Boivin D., Kaelin W.G., Conaway R.C., Conaway J.W., Branton P.E. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 15:2001;3104-3117
52. Raj K., Ogston P., Beard P. Virus-mediated killing of cells that lack p53 activity. Nature. 412:2001;914-917
53. Reid T., Galanis E., Abbruzzese J., Sze D., Wein L.M., Andrews J., Randlev B., Heise C., Uprichard M., Hatfield M., et al. Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520). Phase II viral, immunologic, and clinical endpoints Cancer Res. 62:2002;6070-6079
54. Ries S., Korn W.M. ONYX-015. Mechanisms of action and clinical potential of a replication-selective adenovirus Br. J. Cancer. 86:2002;5-11
55. Ries S.J., Brandts C.H., Chung A.S., Biederer C.H., Hann B.C., Lipner E.M., McCormick F., Korn W.M. Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015). Nat. Med. 6:2000;1128-1133
56. Rothmann T., Hengstermann A., Whitaker N.J., Scheffner M., zur Hausen H. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J. Virol. 72:1998;9470-9478
57. Rudin C.M., Cohen E.E., Papadimitrakopoulou V.A., Silverman S. Jr., Recant W., El-Naggar A.K., Stenson K., Lippman S.M., Hong W.K., Vokes E.E. An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. J. Clin. Oncol. 21:2003;4546-4552
58. Shen Y., Kitzes G., Nye J.A., Fattaey A., Hermiston T. Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein. J. Virol. 75:2001;4297-4307
59. Sherr C.J., McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2:2002;103-112
60. Shieh S.Y., Ahn J., Tamai K., Taya Y., Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14:2000;289-300
61. Stracker T.H., Carson C.T., Weitzman M.D. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature. 418:2002;348-352
62. Thomas A., White E. Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function. Genes Dev. 12:1998;1975-1985
63. Turnell A.S., Grand R.J., Gallimore P.H. The replicative capacities of large E1B-null group A and group C adenoviruses are independent of host cell p53 status. J. Virol. 73:1999;2074-2083
64. White E., Cipriani R., Sabbatini P., Denton A. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65:1991;2968-2978
65. Yu J., Zhang L., Hwang P.M., Rago C., Kinzler K.W., Vogelstein B. Identification and classification of p53-regulated genes. Proc. Natl. Acad. Sci. USA. 96:1999;14517-14522
66. Yueh A., Schneider R.J. Selective translation initiation by ribosome jumping in adenovirus-infected and heat-shocked cells. Genes Dev. 10:1996;1557-1567